| Literature DB >> 35236877 |
Derek C Monroe1,2, Elizabeth A Thomas3,4, Nicholas J Cecchi5,6, Douglas A Granger3,7,8, James W Hicks5, Steven L Small9,10.
Abstract
Blood-based biomarkers of brain injury may be useful for monitoring brain health in athletes at risk for concussions. Two putative biomarkers of sport-related concussion, neurofilament light (NfL), an axonal structural protein, and S100 calcium-binding protein beta (S100B), an astrocyte-derived protein, were measured in saliva, a biofluid which can be sampled in an athletic setting without the risks and burdens associated with blood sampled by venipuncture. Samples were collected from men's and women's collegiate water polo players (n = 65) before and after a competitive tournament. Head impacts were measured using sensors previously evaluated for use in water polo, and video recordings were independently reviewed for the purpose of validating impacts recorded by the sensors. Athletes sustained a total of 107 head impacts, all of which were asymptomatic (i.e., no athlete was diagnosed with a concussion or more serious). Post-tournament salivary NfL was directly associated with head impact frequency (RR = 1.151, p = 0.025) and cumulative head impact magnitude (RR = 1.008, p = 0.014), while controlling for baseline salivary NfL. Change in S100B was not associated with head impact exposure (RR < 1.001, p > 0.483). These patterns suggest that repeated head impacts may cause axonal injury, even in asymptomatic athletes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35236877 PMCID: PMC8891257 DOI: 10.1038/s41598-022-07241-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Athlete demographic information.
| Men | Women | |||
|---|---|---|---|---|
| Club | Varsity | Club | Varsity | |
| Age (years ± SD) | 19.8 ± 2.1 | 20.4 ± 1.3 | 19.9 ± 2.0 | 19.6 ± 1.2 |
| White | 8 | 11 | 6 | 12 |
| Hispanic/Latino | 4 | 0 | 8 | 5 |
| Asian | 1 | 0 | 3 | 0 |
| Hawaiian/Pacific Islander | 1 | 0 | 1 | 0 |
| Not Reported | 0 | 0 | 0 | 5 |
| Lifetime years playing water polo (years ± SD) | 5.8 ± 2.4 | 9.8 ± 3.3 | 5.8 ± 3.4 | 9.5 ± 3.1 |
| Months playing water polo in prior year (months ± SD) | 7.0 ± 3.9 | 11.7 ± .6 | 6.9 ± 4.7 | 10.6 ± 1.2 |
| Average time spent playing in prior year (hours/week ± SD) | 9.5 ± 3.1 | 21.3 ± 3.6 | 9.0 ± 2.6 | 16.3 ± 9.0 |
| Number of players reporting prior mTBI (n/%) | 2 (14%) | 2 (19%) | 4 (22%) | 3(14%) |
Figure 1Diagram of sampling conditions relative to post-tournament samples. Salivary samples from 22 athletes were collected after a practice (“A”) held 5 weeks prior to the tournament. Salivary samples from 20 athletes were collected before a practice (“B”) held 2–4 weeks before the tournament. Salivary samples from 23 athletes were collected after warm-up on Day 1 of a two-day tournament (“C”). Post-tournament salivary samples were collected from 46 athletes within an hour.
Baseline biomarker samples by condition and team.
| Timing of baseline collection | Men | Women | ||
|---|---|---|---|---|
| Club | Varsity | Club | Varsity | |
| 4 (29%) | 0 | 16 (89%) | 0 | |
| S100B, pg/ml (median/IQR) | 58.51 (22.95, 335.70) | – | 38.36 (17.77, 52.27) | – |
| NfL, pg/ml (median/IQR) | 3.39 (1.12, 25.38) | – | 2.39 (1.03, 29.5) | – |
Players with post-tournament samples (n/% of baseline) | 2 (50%) | 11 (69%) | ||
| 0 | 0 | 0 | 22 (100%) | |
| S100B, pg/ml (median/IQR) | – | – | – | 37.35 (14.46, 65.76) |
| NfL, pg/ml (median/IQR) | – | – | – | 1.03 (1.03, 6.91) |
| Players with post-tournament samples (n/% of baseline) | 0 | 0 | 0 | 15 (68%) |
| 10 (71%) | 11 (100%) | 2 (11%) | 0 | |
| S100B, pg/ml (median/IQR) | 51.26 (23.85, 105.72) | 156.84 (41.38, 235.38) | 49.04 (18.01) | – |
| NfL, pg/ml (median/IQR) | 1.01* | 4.93 (1.97, 23.89) | 1.98 (1.01) | – |
| Players with post-tournament samples (n/% of baseline) | 9 (90%) | 8 (73%) | 1 (50%) | 0 |
*Indicates all samples were the same and thus median, 1st quartile, and 3rd quartile are equal.
Figure 2Differences in head impact exposure by competitive team. (a) Distribution of head impact frequency per athlete. (b) Distribution of peak linear acceleration (PLA) per impact. (c) Distribution of peak rotational acceleration (PRA) per impact. (d) Distribution of cumulative head impact magnitude (wCHI) per athlete. (e) Predicted (95% confidence intervals) number of head impacts sustained by men’s (n = 25), women’s (n = 40), club (n = 32), and varsity (n = 33) teams. (f) Predicted (95% confidence intervals) wCHI sustained by men’s (n = 25), women’s (n = 40), club (n = 32), and varsity (n = 33) teams. *Denotes significant difference between groups, p < 0.05.
Figure 3Dose–Response relationships between head impact exposure and salivary biomarkers. (a) Modeled relationship between post-tournament salivary S100B and the number of head impacts sustained during the tournament after adjustment for pre-tournament S100B (n.s.). (b) Modeled relationship between post-tournament salivary S100B and wCHI sustained during the tournament after adjustment for pre-tournament S100B (n.s.). (c) Modeled relationship between post-tournament salivary NfL and the number of head impacts sustained during the tournament after adjustment for pre-tournament NfL (RR = 1.151; 95% CI 1.031, 1.285; p = 0.025). (d) Modeled relationship between post-tournament salivary NfL and wCHI sustained during the tournament after adjustment for pre-tournament NfL (RR = 1.008; 95% CI 1.002, 1.013; p = 0.014). Dashed lines represent 95% Confidence intervals.
Figure 4Differences in baseline salivary biomarker concentrations by sampling condition. Modeled relationship between baseline salivary S100B (a) and NfL (b) and sampling condition ordered by increasing proximity to physical exertion: ~ 15 min post-warmup, ~ 1 h after practice, and before practice (≥ 22 h after the last practice). *Denotes significant difference between conditions, p < 0.05.